Pisarska M, Sajdak S
Division of Gynecological Surgery, Department of Gynecology and Obstetrics, K. Marcinkowski University of Medical Sciences, Poznań, Poland.
Eur J Gynaecol Oncol. 2003;24(6):490-4.
The aim of this study was the urodynamic assessment of lower urinary tract disturbance intensity (especially urinary incontinence) among irradiated women after the surgical treatment of cervical cancer.
The analysis included 34 patients after radical hysterectomy and following radiotherapy for cervical cancer in clinical Stage Ib. Only patients without any previous urogynecological disorders were included. Urodynamic diagnostics was performed two weeks after oncological treatment termination.
Urodynamic parameter changes were clearly present at all stages of functional diagnostics. The most remarkable changes included decreased bladder capacity (mean 196 ml) and residual urine volume (mean 19 ml). The mean value of maximal urine flow rate obtained from uroflowmetry was 26 ml/s, but for 20 women it was lower than 20 ml/s. Voiding time and flow time were abnormally delayed with the significant difference of five seconds. Bladder sensation points were increased and maximum cystometric capacity was decreased to 270 ml during filling cystometry. Bladder compliance was 28 ml/cm H2O on average; for the majority of patients it was below 20. Detrusor pressure was increased in 23 cases above 20 cm H2O and mean isometric pressure was 34 cm H2O. Urethral pressures were low, especially while taking effort. Urinary incontinence was diagnosed in 30% of the cases.
The obtained results allow us to conclude that voiding disorders after combined radiotherapy and surgery are often and mainly apply to the detrusor muscle with the domination of functional disturbances. It seems that early quantitative and qualitative changes depend on combined therapy with a standard dose pattern. The presence of functional disorders after oncological treatment should be considered in the planning of prevention and further treatment. Urinary incontinence restricts patients' activity, affects the quality of their lives and is the cause of patient discomfort. Many patients suffering from lower urinary tract pathologies pose a therapeutic problem caused by lack of information.
本研究旨在对宫颈癌手术治疗后的受辐照女性下尿路功能障碍强度(尤其是尿失禁)进行尿动力学评估。
分析纳入了34例临床Ib期宫颈癌根治性子宫切除术后接受放疗的患者。仅纳入既往无任何泌尿妇科疾病的患者。在肿瘤治疗结束两周后进行尿动力学诊断。
在功能诊断的各个阶段均明显出现尿动力学参数变化。最显著的变化包括膀胱容量(平均196毫升)和残余尿量(平均19毫升)减少。尿流率测定获得的最大尿流率平均值为26毫升/秒,但20名女性的该值低于20毫升/秒。排尿时间和尿流时间异常延迟,差异达5秒。膀胱充盈测压时膀胱感觉点增加,最大膀胱容量降至270毫升。膀胱顺应性平均为28毫升/厘米水柱;大多数患者低于20。23例患者逼尿肌压力升高超过20厘米水柱且平均等长压力为34厘米水柱。尿道压力较低,尤其是在用力时。30%的病例诊断为尿失禁。
所得结果使我们得出结论,放疗和手术联合治疗后的排尿障碍常见且主要累及逼尿肌,以功能障碍为主。早期的定量和定性变化似乎取决于标准剂量模式的联合治疗。在预防和进一步治疗的规划中应考虑肿瘤治疗后功能障碍的存在。尿失禁限制患者活动,影响生活质量,是患者不适的原因。许多患有下尿路疾病的患者因信息缺乏而带来治疗难题。